MedPath

Comparison of the Central Venous Catheter Insertion Techniques

Not Applicable
Completed
Conditions
Child
Surgery
Registration Number
NCT02312388
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to compare the differences in central venous catheter insertion time, success rate, and complication between thin-wall needle technique and catheter-over-the-needle technique for central venous catheterization in children.

Detailed Description

Catheterization was performed using ultrasound with an "out-of-plane" approach by inserting the introducer needle (thin-wall needle technique) or Angiocath Plus™ catheter (catheter-over-the-needle technique) in 45 - 60° to the patient's skin while viewing the vein in a cross section.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
138
Inclusion Criteria
  • surgery under general anesthesia
  • require central venous catheterization
Exclusion Criteria
  • hematoma in central vein
  • central vein anomaly
  • catheterization site infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Guide-wire insertion timeinterval between skin penetration and removal of the needle or catheter after guide wire insertion, an expected average of 80 seconds
Secondary Outcome Measures
NameTimeMethod
Time to first puncture of central veininterval between skin penetration of the needle or catheter and flashback of blood, an expected average of 25 seconds
Total time of central venous catheter insertioninterval between skin penetration of the needle or catheter and installation of the indwelling catheter, an expected average of 3 minutes
Number of central vein puncture trialup to 5 times, an expected average observation time of 25 seconds
Number of guide-wire insertion trialup to 5 times, an expected average observation time of 80 seconds

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.